A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples